These associations were independent of participants having follow-up diagnoses of MCI or dementia.<h4>Conclusion</h4>Our findings suggest that after accounting for biomarkers of AD pathology, CSF NPTX2 is associated with slower longitudinal atrophy in AD-signature and aging-related regions. The gene discussed is NPTX2; the disease is Alzheimer disease.